Navigatie
Marktvooruitzichten Voorraadscreener Dividend kalender Evenementen kalender Waardering van aandelen Markten Nieuws
Probeer gratis

Infinity Pharmaceuticals

NASDAQ INFI
$0.0000 0.0000 -%
Today share price
VS
Sector: Healthcare Industry: Biotechnology
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Rating Finrange

Показатель: 16 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

-
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.
-37.72M
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.
2.17
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.
89.89M
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.
-

Upcoming events Infinity Pharmaceuticals

All events
No upcoming events scheduled

Overview

Financials

Key Metrics

Dividends

Industry overview

Events

Stock chart Infinity Pharmaceuticals

Stock analysis Infinity Pharmaceuticals

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.
- 28.88
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.
- 4.03
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.
0.91 11.32
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.
0.91 0.25
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.
106.69 10.75

Price change Infinity Pharmaceuticals per year

1.04$ 5.98$
Min Max

Summary analysis Infinity Pharmaceuticals

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure Infinity Pharmaceuticals

Revenue and net income Infinity Pharmaceuticals

All parameters

Stock news Infinity Pharmaceuticals

All news
24 juli 2023 в 15:55

Infinity Pharmaceuticals Ends Merger Agreement With MEI Pharma

24 juli 2023 в 15:55

Infinity Pharmaceuticals Ends Merger Agreement With MEI Pharma

23 februari 2023 в 15:46

MEI Pharma to Buy Infinity Pharmaceuticals in All-Stock Deal

23 februari 2023 в 15:41

MEI Pharma to Buy Infinity Pharmaceuticals in All-Stock Deal

2 augustus 2021 в 17:34

Infinity Pharmaceuticals upgraded to overweight from neutral at J.P. Morgan

About company Infinity Pharmaceuticals

Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 1/1b clinical trials for the treatment of triple negative breast cancer, solid tumors, and ovarian cancer. The company has strategic alliances with Intellikine, Inc. to discover, develop, and commercialize pharmaceutical products targeting the delta and/or gamma isoforms of PI3K; Verastem, Inc. to research, develop, commercialize, and manufacture duvelisib and products containing duvelisib; and PellePharm, Inc. to develop and commercialize rights to its hedgehog inhibitor program, IPI-926, a clinical-stage product candidate, as well as collaboration agreements with Arcus Biosciences, Inc., F. Hoffmann-La Roche Ltd., and Bristol Myers Squibb Company. Infinity Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Cambridge, Massachusetts.
Address:
1100 Massachusetts Avenue, Cambridge, MA, United States, 02138
Company name: Infinity Pharmaceuticals
Issuer ticker: INFI
ISIN: US45665G3039
Country: VS
Exchange: NASDAQ
Currency: $
IPO date: 2000-07-28
Sector: Healthcare
Industry: Biotechnology
Site: https://www.infi.com

On which stock exchange are Infinity Pharmaceuticals (INFI) stocks traded?

Infinity Pharmaceuticals (INFI) stocks are traded on NASDAQ.

What is the ticker of Infinity Pharmaceuticals stocks (INFI)?

The stock ticker of Infinity Pharmaceuticals’s stocks or in other words, the code is INFI. The stocks are currently listed on the NASDAQ exchange.

In which sector and industry does Infinity Pharmaceuticals (INFI) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, Infinity Pharmaceuticals (INFI) belongs to the «Healthcare» sector and the «Biotechnology» industry.

In what currency are Infinity Pharmaceuticals (INFI) stocks traded?

Infinity Pharmaceuticals (INFI) stocks are traded on the NASDAQ exchange in dollars.

What is the price of Infinity Pharmaceuticals (INFI) stocks today?

The current price of Infinity Pharmaceuticals stocks on 20.05.2024 is 0 dollars. per share.

What is the dynamics of Infinity Pharmaceuticals (INFI) stocks from the beginning of the year?

Infinity Pharmaceuticals (INFI) quotes have increased by 0% from the beginning of the year up to 0 dollars. per 1 stocks.

How much did Infinity Pharmaceuticals (INFI) stocks increase in мае 2024?

This month Infinity Pharmaceuticals (INFI) quotes have increased by 0% to 0 dollars. per share.

How much are Infinity Pharmaceuticals (INFI) stocks worth?

Today, on October, 20.05.2024 Infinity Pharmaceuticals’s (INFI) stocks cost 0 dollars..

What is the market capitalization of Infinity Pharmaceuticals (INFI)?

Capitalization is the market value of Infinity Pharmaceuticals (INFI) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 20.05.2024, the market capitalization of Infinity Pharmaceuticals (INFI) is estimated at about 0 dollars.